Risk factors
Bone Biologics (BBLG) risk factors
Item 1A of every Bone Biologics Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors72 risks1 new15 reworded
Bone Biologics restructured its entire risk section, completely swapping the content of multiple risk categories between headers. Federal net operating loss carryforwards increased from $34,585,000 as of December 31, 2024 to $46,140,000 as of December 31, 2025. A new risk was added concerning potential expenses, litigation, and trade secret exposure related to intellectual property.
Filed Mar 02, 2026 - FY2024 10-K risk factors71 risks
Bone Biologics faces severe going concern doubts, relying on $4.1M cash to fund operations through late 2025.
Filed Feb 26, 2025